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A photoactivatable small molecule probe for the in vivo capture 
of polyketide intermediates    
Samantha L. Kilgour,[a] Robert Jenkins[a] and Manuela Tosin*[a] 
 
Abstract: A photolabile carba(dethia) malonyl N-acetylcysteamine 
derivative was devised and prepared for the trapping of biosynthetic 
polyketide intermediates following light activation. From the lasalocid 
A polyketide assembly in a mutant strain of the soil bacterium S. 
lasaliensis, a previously undetected cyclised intermediate was 
identified and characterised, providing a new outlook on the timing of 
substrate processing.  
Polyketide natural products constitute an abundant family of 
secondary metabolites comprising prominent pharmaceuticals 
and agrochemicals such as fidaxomicin and avermectin.[1] They 
are biosynthesized by multifunctional enzymes known as 
polyketide synthases (PKSs) through a common pathway: this 
involves multiple decarboxylative Claisen condensations of acyl 
carrier protein (ACP) or CoA-bound malonyl  units onto 
ketosynthase- (KS) bound acyl groups (Fig. 1A). Newly generated 
ACP- bound intermediates ‘grow’ in length and chemical 
complexity thanks to the action of reductive enzymes (e.g. 
ketoreductases, dehydratases, and enoylreductases, ERs) until 
the end polyketide product is released from a PKS (typically by 
thioesterase-, TE-, mediated hydrolysis/cyclisation); further 
enzymatic tailoring ultimately afford the mature bioactive natural 
product.  
PKSs are classified as modular or iterative and into different 
types on the basis of their structural organization and modus 
operandi.[2] A detailed knowledge of PKS biosynthesis pathways 
constitutes the basis of rational enzyme engineering for the 
production of commodity and high value chemicals. [3]  Over time 
key insights into PKS workings have been provided by molecular 
biology, enzymology, analytical chemistry and structural studies. 
[3b, 4] Nonetheless challenges in PKS studies remain; these are 
mainly associated with limitations in our ability to closely monitor 
the biocatalysis in its natural context and thereby determine the 
exact mechanism and order of enzymatic transformations.  
In our group we have devised a chemical approach for 
polyketide biosynthetic investigations based on the use of ‘chain 
termination’ probes capable of intercepting PKS biosynthetic 
intermediates throughout product assembly. The probes are 
carba(dethia) N-acetylcysteamine (NAc) derivatives which mimic 
the ACP-malonyl extender units utilised in polyketide formation (2, 
Fig. 1) and have been utilised for in vitro and in vivo studies to 
shed light on previously unknown details of complex polyketide 
formation, such as that of polyethers, macrolides and  
 
Figure 1. (A) Premature polyketide chain termination for intermediate capture 
via a nonhydrolysable carba(dethia) malonyl N-acetylcysteamine 2: this 
competitively interferes with polyketide chain assembly (dashed pathway) to off-
load enzyme-bound intermediates (3).[5a] (B) Newly devised photolabile DMNB 
probe (4) for polyketide intermediate capture following light activation (h). 
Legend: ACP= Acyl Carrier Protein; AT= Acyl Transferase; KS= Ketosynthase; 
KR= ketoreductase.    
thiotetronates.[5-7] More recently the chemical chain termination 
strategy was successfully extended to the study of nonribosomal 
peptide synthetases via the use of nonhydrolysable mimics of 
PCP-bound amino acids. [8]  
In utilising our chemical tools for the investigation of natural 
product pathways in Gram-positive bacteria, Gram-negative 
bacteria and fungi, [7a] we found that chemical modifications in the 
probe structure greatly affect its bioavailability and intermediate 
capture ability in vivo. For instance, variation of the N-acyl moiety 
of ester-masked probes (1) affects both cell permeation and the 
extent of in vivo ester hydrolysis of 1 to generate the active probe 
2. [6c] Besides, the use of a labile acetoxymethyl ester as a -
ketoacid protecting group for 2 leads to increased titers of 
captured intermediates, likely due to increased amounts of 2 
generated in situ. [6c] Nonetheless tool development is still needed 
in order to improve our ability to dissect challenging biosynthetic 
pathways.  
Amongst the most attractive approaches employed to study, 
control and modulate biological process is the use of light: indeed 
photosensitive groups do not require the use of (bio)chemical 
reagents for their cleavage/activation, and this last can be 
selectively achieved at biologically non-damaging wavelengths 
with high spatio-temporal precision.[9] Several photoactivatable 
moieties have been devised and employed in chemical biology for 
a wide range of applications,[10] such as aryl azides, 
benzophenones and diaziridines to generate electrophiles for 
photoaffinity receptor tagging;[11] phenacyl, benzoin and 
nitrobenzyl protecting groups for the ‘uncaging’ of 
effector/signaling molecules;[12] and azobenzenes as 
conformational switches of gene expression[13] amongst many 
others. In the context of natural products, photolabile ‘unnatural’ 
amino acids have been incorporated into proteins and peptides 
via feeding experiments and genetic encoding for protein/peptide 
labelling. [14] Furthermore, several medically relevant secondary 
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Figure 2. (A) Overview of advanced putative intermediate capture from the lasalocid A polyketide synthase during the fermentation of S. lasaliensis ACP12 (S970A) 
via the newly devised photolabile probe 4. The stereochemistry of the putative captured species 7-10 has yet to be established. (B) UPLC-HRMSn characterization 
of the newly detected putative intermediate 10 following light activation of 4.   
 
metabolites bearing photoactive moieties have been chemically 
synthesized in order to identify their natural product target and 
mechanism of action. [15]  
To the best of our knowledge photoactivatable small 
molecule have yet to be utilised in the study of secondary 
metabolite assembly. Therefore we decided to utilise a 
photolabile protecting group to mask the active -ketoacid moiety 
of our polyketide chain termination probes to establish whether 1) 
the group could be photolysed in vivo during live bacterial 
fermentation, and 2) it could be advantageous in the capture of 
biosynthetic intermediates. The photoactive group chosen for our 
studies was the 4,5-dimethoxy-2-nitrobenzyl (DMNB) group, 
providing straightforward synthetic incorporation and cleavage 
upon irradiation at 365 nm, generating a low toxicity by-product 
(o-nitrosobenzaldehyde).[16] The DMNB moiety has been used to 
protect alcohols, thiols, selenols, amines, phosphates and 
carboxylic acids for biological applications. [12, 15-17]  Various 
structural modifications of DMNB have been devised to increase 
its photolysis quantum yield; this has been shown to be 
dependent on the nature of the leaving group in the DMNB 
substrate, with esters displaying the lowest quantum yield in 
comparison to ethers and amines. [9a]  
The preparation of the DMBN probe 4 (Fig. 1) as the first 
photoactivable tool for polyketide biosynthetic investigations was 
accomplished from -aminobutyric acid 5 in 3 steps (Scheme 1S 
and related Supplementary Information, SI). Photolysis studies of 
4 in different organic solvent and buffers were performed 
employing different light sources. 4 could be quantitatively 
photolysed over a period of 2-4 hours in water by irradiation with 
either a KiloArc™ Broadband Arc Lamp (1000 W, 2 hours) or with 
an in-house built light box containing a circular 22W UVA lamp in 
water (4 hours), or in MYM Streptomyces medium (6 hours) at 
similar concentrations (0.5- 2.0 mM, SI). We then trialed its use in 
vivo during the growth of S. lasaliensis ACP12 (S970A), a model 
bacterial strain extensively utilised for the investigation of the 
antibiotic lasalocid A assembly in our labs. This mutant strain, for 
which the last ACP of the lasalocid A synthase is inactivated, has 
been found to harbor several enzyme-bound biosynthetic 
intermediates by us extensively characterised, and to generate 
unnatural polyether species such as 7 in the presence of ‘chain 
termination’ probes such as 2.[6]   
Both liquid and agar-plate cultures of the S. lasaliensis 
ACP12 (S970A) strain were supplemented with 4 (without 
photolysis), either in a single amount on day 1 of bacterial growth 
or in multiple smaller portions throughout days 2 to 5 of 
fermentation to achieve a similar final concentration (2.5 mM). 4 
was found to be almost quantitatively hydrolysed over 5 days in 
organic extracts belonging to ‘day 1’ supplementation 
experiments, whereas it remained almost intact in samples 
deriving from ‘2-to-5’ daily supplements (Fig. 3S). This indicated 
that 4 is a relatively poor substrate for in vivo esterases, unless 
incubated in fermentation conditions for prolonged periods of time. 
In all the extracts belonging to unphotolysed samples, traces of 
the unnatural polyketide 7 and its linear unoxidised precursor 9 
(both deriving from the off-loading of intermediates bound to the 
lasalocid A synthase) were detected and characterised as 
previously reported (Fig. 4S and 5S),6 indicating that even the 
presence of a small amount of 2 leads to intermediate capture. 
The same in vivo experiments were then carried out subjecting 
the bacterial solid and liquid cultures to light irradiation via the in-
house built UVA light box (as detailed in the SI). Culture irradiation 
was carried out for up to 2 hours daily over a period of 5 days in 
order to minimise disruption on cell growth and metabolism. 
Exposure to light irradiation did not affect cell growth and 
deprotection of 4 followed by decarboxylation to 2 was achieved 
in vivo; the extent of it varied upon culture conditions and was 
much more evident in liquid cultures supplemented with daily 
doses of 4 (Fig. 6S). Intriguingly, the most interesting results in 
terms of biosynthetic intermediate capture came from the 
photolysis of liquid cultures supplemented with 4 in day 1. Besides 
the previously detected 7 and 9 generated in substantially higher 
amounts (Fig. 7S and 8S), organic extract analyses by UPLC-
HRMS revealed the presence of a putative oxidised and cyclized 
nonaketide, possibly dehydrated (10, Fig. 2 and 9S). This species 
organic 
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was characterized by HR-MS2 experiments, which displayed an 
m/z fragment of 377 characteristic of the lasalocid A polyether part 
of the molecule (Fig. 2B); a possibly related species weighing 2Da 
less and displaying an m/z 377 fragment was also observed (Fig. 
10S and 11S). Recent profiling of lasalocid A polyketide bio-
assembly with second-generation chain termination probes have 
allowed us to off-load and capture several putative biosynthetic 
intermediates, including partially and fully processed linear 
nonaketides such as 8 (Fig. 2).[6c] To date only putative 
undecaketides and dodecaketides featuring polyether moieties 
had been identified; these would derive from the processing of 
linear enzyme-bound polyketide chains by the tailoring enzymes 
LasC (an epoxidase) and LasB (an epoxide hydrolase).[6] The 
characterization of a putative nonaketide polyether species 10 in 
the current study suggests that either the linear nonaketide 8 is 
oxidised and processed by LasC and LasB following the chemical 
off-loading of a fully processed PKS-bound octaketide from 
module 9; or that the tailoring epoxidation-epoxide hydrolysis 
cascade might take place on PKS-bound intermediate(s) earlier 
than previously envisaged.[6a]  Whereas recombinant LasC and 
LasB are capable of processing substrate mimics of different 
nature and complexity,[18] the nature of the true substrates for 
these enzymes in vivo remains debatable. Nonetheless the 
detection of 9 and other putative captured species in specific 
microorganism fermentation and photolysis conditions exposes 
how the timing and the flux of polyketide/polyether intermediate 
formation is much susceptible to local and global perturbations 
and still holds several intriguing aspects worthy of further 
investigation and exploitation.  
In summary we have here obtain novel insights on lasalocid 
A polyketide assembly utilising a novel light-activatable tool in vivo. 
Further investigations into the modus operandi of 4 and the 
development of other light-controlled tools for biosynthetic studies 
[19] holds the promise to unveil yet unknown aspects of modular 
as well as iterative natural product synthases. 
Experimental Section 
The synthesis of 4, its use and detailed UPLC-HRMSn analyses 
of lasalocid A captured intermediates are described in the 
Supplementary information (SI). 
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